BII
CRBP icon

Bainco International Investors’s Corbus Pharmaceuticals CRBP Stock Holding History

Bainco International Investors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-667
Closed -$169K – 93
2016
Q4 		$169K Hold
667
– – 0.03% 80
2016
Q3 		$136K Buy
+667
New +$83K 0.02% 79

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bainco International Investors's CRBP Position: Q1 2017 in Review

Bainco International Investors sold out of Corbus Pharmaceuticals (CRBP) in Q1 2017, closing a stake of 667 shares — an estimated $169K sold.

Bainco International Investors first reported a position in CRBP in Q3 2016 and held it in 2 quarters. The position peaked at $169K in Q4 2016. 54 funds tracked by Wall St. Rank hold CRBP as of Q1 2017.

  • Bainco International Investors reported no remaining Corbus Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Bainco International Investors sold 667 Corbus Pharmaceuticals shares in Q1 2017, an estimated $169K.
  • Bainco International Investors first reported a position in Corbus Pharmaceuticals in Q3 2016 and held it in 2 quarters.
  • Bainco International Investors's Corbus Pharmaceuticals position peaked at $169K in Q4 2016.
  • 54 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2017.

Based on Bainco International Investors's 13F filing for Q1 2017, filed 16 May 2017.